Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 1.00 |
| ▸ | LMNA | P02545 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | P2RX4 | Q99571 | 6/20 | 0.42 |
| ▸ | BCHE | P06276 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | P2RX1 | P51575 | 3/20 | 0.38 |
| ▸ | P2RX3 | P56373 | 3/20 | 0.38 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.38 |
| ▸ | PTBP1 | P26599 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL367474 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2LMNAMEN1KMT2AP2RX4 | |
| SCHEMBL29367804 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2LMNAMEN1KMT2AP2RX4 | |
| SCHEMBL23705539 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2LMNAMEN1KMT2AP2RX4 | |
| Carbimide SCHEMBL10800076 | 0.95 | SMN1; SMN2 (0.90) | SMN1; SMN2LMNAMEN1KMT2AP2RX4 | |
| 1,2-Dichloroethane SCHEMBL28697158 | 0.95 | SMN1; SMN2 (0.90) | SMN1; SMN2LMNAMEN1KMT2AP2RX4 | |
| SCHEMBL8608444 | 0.93 | SMN1; SMN2 (0.86) | SMN1; SMN2LMNAMEN1KMT2AP2RX4 | |
| Dimethylformamide SCHEMBL7714545 | 0.92 | SMN1; SMN2 (0.84) | SMN1; SMN2LMNAMEN1KMT2AP2RX4 | |
| SCHEMBL8063974 | 0.91 | SMN1; SMN2 (0.82) | SMN1; SMN2LMNAMEN1KMT2AP2RX4 | |
| SCHEMBL8608446 | 0.91 | SMN1; SMN2 (0.82) | SMN1; SMN2LMNAMEN1KMT2AP2RX4 | |
| SCHEMBL9188247 | 0.90 | SMN1; SMN2 (0.82) | SMN1; SMN2LMNAMEN1KMT2AP2RX4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 17811 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122036845-A | Cathepsin B-sensitive fatty acid-doxorubicin prodrug, albumin nanoparticle thereof, and preparation method and application thereof | 沈阳药科大学 | 2026-05-15 | — | — | CN | claimed |
| CN-122036842-A | Cathepsin B-sensitive fatty acid-irinotecan prodrug and albumin nanoparticle thereof, and preparation method and application thereof | 沈阳药科大学 | 2026-05-15 | — | — | CN | claimed |
| CN-122011088-A | Cyclic peptide compound and preparation method and application thereof | 甫康生物科技(上海)股份有限公司 | 2026-05-12 | — | — | CN | claimed |
| US-20260109730-A1 | Process For The Preparation Of (3Beta,24S)-25,25,25-Trifluoro-3-Methyl-26,27-Dinorergost-5-ene-3,24-Diol | IND CHIMICA SRL (IT) | 2026-04-23 | — | — | US | claimed |
| EP-4720072-A2 | RAS INHIBITORS | Revolution Medicines, Inc. (US) | 2026-04-08 | — | — | EP | claimed |
| US-20260078133-A1 | RAS INHIBITORS | Revolution Medicines, Inc. | 2026-03-19 | — | — | US | claimed |
| US-20260078124-A1 | METHODS OF PREPARING ERGOLINE ANALOGS | UNIV CALIFORNIA (US) | 2026-03-19 | — | — | US | claimed |
| EP-4688790-A1 | MACROCYCLIC RAS INHIBITORS | Revolution Medicines, Inc. (US) | 2026-02-11 | — | — | EP | claimed |
| US-20260028353-A1 | MACROCYCLIC RAS INHIBITORS | WILMINGTON TRUST, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT | 2026-01-29 | — | — | US | claimed |
| US-12486286-B2 | Process and polymorphic forms of bictegravir and its pharmaceutically acceptable salts or co-crystals thereof | LAURUS LABS LIMITED (IN) | 2025-12-02 | — | — | US | claimed |
| EP-0070021-B1 | PROCESS FOR THE PREPARATION OF CYCLIC HEXAPEPTIDE | MERCK & CO. INC. (US) | 1986-01-08 | — | — | EP | claimed |
| US-4560504-A | Carboxyl anchored immobilized antibodies | UOP INC. (US) | 1985-12-24 | — | — | US | claimed |
| EP-0023854-B1 | SOLUBLE POLYMERS POSSESSING ANTICOAGULATING PROPERTIES, PROCESS FOR PREPARING THEM AND THEIR USE AS DRUGS WITH ANTICOAGULATING ACTION | Fougnot, Christine (FR) | 1984-12-12 | — | — | EP | claimed |
| EP-0124068-A1 | New derivatives of biliary acids, process for the production thereof and pharmaceutical compositions containing the same | LEHNER A.G. (CH) | 1984-11-07 | — | — | EP | claimed |
| US-4434228-A | WITH POILYCARBOXYLIC ACID | GENEX CORPORATION (US) | 1984-02-28 | — | — | US | claimed |
| EP-0090100-A1 | Insoluble polymers with anti-coagulating properties, articles containing them and methods of manufacture | Fougnot, Christine (FR) | 1983-10-05 | — | — | EP | claimed |
| EP-0070021-A1 | Process for the preparation of cyclic hexapeptide | MERCK & CO. INC. (US) | 1983-01-19 | — | — | EP | claimed |
| EP-0061187-A1 | Bicyclic lactams as antihypertensives | MERCK & CO. INC. (US) | 1982-09-29 | — | — | EP | claimed |
| EP-0023854-A1 | Soluble polymers possessing anticoagulating properties, process for preparing them and their use as drugs with anticoagulating action | Fougnot, Christine (FR) | 1981-02-11 | — | — | EP | claimed |
| US-4238473-A | LOWER CARBOHYDRATES HAVING A BRIDGING ARM GLYCOSIDICALLY LINKED TO AN ALDOSE MOIETY | CHEMBIOMED LIMITED (CA) | 1980-12-09 | — | — | US | claimed |